spacer
home > epc > spring 2009 > ediary time
PUBLICATIONS
European Pharmaceutical Contractor

eDiary Time

Back in the days of pen and paper clinical trials monitoring, something familiar but disconcerting caught my attention as I got out of the car. There in the next car sat a patient busy filling in his diary card with peak expiratory flow (PEF) readings and symptoms for the past month. Mentioning this to the investigating consultant, he called the patient in, commended him for having a complete diary, and then as he rubbed his finger over it, said, “oh dear the ink is still wet!” Having observed this, I concluded that there had to be a better way of recording diary data. The answer came in the early 1990s with the development of e-spirometric diaries. Chowienczyk et al compared paper versus electronic recording of spirometry data, demonstrating that 33 per cent of completed entries were either invented, mistimed or misread, and were often retrospectively entered (1). Since then, other studies have confirmed that paper diaries often contain invented data (2,3).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Initially qualifying as an entomologist, Aleck Harrison swiftly moved from ‘bugs to drugs’ and spent 34 years with Boehringer Ingelheim Ltd. Evolving from CRA to managing international respiratory studies, he advised a number of companies on spirometric diary development. Having semiretired, he started the consultancy of AJH Partners (Contract Research and Consultancy). Amongst his recent activities, he has supported respiratory companies, including Vitalograph Ltd, with the introduction and development of their centralised spirometry system.

spacer
Aleck Harrison
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement